The Future of Health Grant acceleration program, led by CSS and EPFL Innovation Park, received a record-breaking 243 applications for its spring cohort. Six of them have now been selected. And to push innovation even further, the FoHG is launching its “Pilot Factory”, an initiative that will facilitate multi-stakeholder collaborations to test solutions in real-world settings.
The FoHG has selected six startups from a record 243 applications to receive strategic and hands-on support, including up to CHF 90,000 in non-dilutive funding, personalized coaching, and access to a network of experts and key industry players. Each startup can progress through the three maturity levels of the program.
Level 1 - Ignition Grant - CHF10k - 3 months
OncoBoard: Organizing and prioritizing cancer data from multiple sources to create personalized, patient-centric reports for better treatment decisions
VAir: A non-invasive, automated breath analysis platform detecting multiple respiratory viruses in under 3 minutes
Level 2 - POC Grant - CHF30k - 6 months
Onescope: A MedTech innovator revolutionizing respiratory care with the Pneumoscope, a 3-in-1 AI-powered device for diagnosing and monitoring lung health
Clee Medical: Enhancing neurosurgery with AI-driven image visualization, improving intraoperative decision-making for safer, more precise procedures
DigeHealth: A 24/7 monitoring solution for bowel diseases, focusing on post-operative recovery and prevention through real-time health insights
Level 3 - Validation Grant - CHF50k - 12 months
Neuria: A gamified digital therapeutic intervention designed to recalibrate the brain’s reward system and reduce unhealthy food cravings
Launching the “Pilot Factory”, a new real-world testing ground
In addition to the tailored support provided by expert partners, some selected startups will now have the opportunity to test their solutions in real-world conditions. With the launch of the “Pilot Factory”, the Future of Health Grant is initiating multi-stakeholder pilot projects that bring together healthcare providers, patient associations, pharmaceutical companies, insurers, and innovators. The goal is to test and validate innovative health solutions in real environments, fostering collaboration across the healthcare ecosystem.
Shaping the future of healthcare through digital technologies
FoHG aims to drive greater personalization of care, more precise diagnostics, real-time patient monitoring, reduced delays, and lower costs by bring together key innovation players.
For nearly a decade, CSS has been investing in connected health, playing an active role at every stage of innovation through initiatives such as the CSS Health Lab (in partnership with ETH Zurich and the University of St. Gallen) and its investment subsidiary, SwissHealth Ventures.
The EPFL Innovation Park contributes its scientific expertise, startup support, and vast network, helping to develop cutting-edge digital health solutions in French-speaking Switzerland.
(Press release / SK)
Picture: Rawpixel
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
Please login or sign up to comment.
Commenting guidelines